Biodefense watchdog goes dark

The Sunshine Project, a Texas-based group that has monitored safety and oversight issues in research on bioterror agents, suspended operations on February 1, according to the group's linkurl:Web site.;http://www.sunshine-project.org/ Ed Hammond, who heads the non-profit operation and whom I've spoken with a handful of times, has gained a reputation as something of a pitbull tearing on the pantleg of the US's growing biodefense research program. One of the group's main strategies has been simply

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The Sunshine Project, a Texas-based group that has monitored safety and oversight issues in research on bioterror agents, suspended operations on February 1, according to the group's linkurl:Web site.;http://www.sunshine-project.org/ Ed Hammond, who heads the non-profit operation and whom I've spoken with a handful of times, has gained a reputation as something of a pitbull tearing on the pantleg of the US's growing biodefense research program. One of the group's main strategies has been simply to file one Freedom of Information Act after another requesting details from government agencies and universities on research on bioterrorist agents, and then publicizing the results - or lack thereof, when the sources refused to provide them. Hammond wasn't immediately available when I phoned and Emailed him for more details, but the reason for the group's closing is lack of funds, the Chronicle of Higher Education linkurl:reports.;http://chronicle.com/daily/2008/02/1569n.htm "The end of their operations would create a vacuum," Richard Ebright, a professor of microbiology at Rutgers University, told the Chronicle. "We'll go back to silence." Last year, the Sunshine Project linkurl:exposed;http://www.the-scientist.com/news/display/53626/ several instances of biosafety lapses at labs around the US working with dangerous pathogens, prompting Congressional review. Hammond has also argued against the need for a new linkurl:bio-agro defense facility.;http://www.the-scientist.com/news/display/24290/
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies